Healthcare provider profile · identity verified

Letterio Asciuto, MD

Internal Medicine · SOUTHINGTON, CT · NPI 1003824939

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	648	196
Lisinopril	Lisinopril	346	98
Metformin Hcl	Metformin Hcl	313	93
Alprazolam	Alprazolam	310	73
Levothyroxine Sodium	Levothyroxine Sodium	275	79
Amlodipine Besylate	Amlodipine Besylate	236	81
Metoprolol Succinate	Metoprolol Succinate	156	42
Rosuvastatin Calcium	Rosuvastatin Calcium	147	49
Escitalopram Oxalate	Escitalopram Oxalate	144	39
Tamsulosin Hcl	Tamsulosin Hcl	144	44
Omeprazole	Omeprazole	134	42
Pantoprazole Sodium	Pantoprazole Sodium	125	42
Simvastatin	Simvastatin	123	38
Eliquis	Apixaban	120	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	110	29
Losartan Potassium	Losartan Potassium	104	27
Pravastatin Sodium	Pravastatin Sodium	100	29
Albuterol Sulfate Hfa	Albuterol Sulfate	99	27
Olmesartan Medoxomil	Olmesartan Medoxomil	93	24
Metoprolol Tartrate	Metoprolol Tartrate	88	30
Pioglitazone Hcl	Pioglitazone Hcl	88	21
Zolpidem Tartrate	Zolpidem Tartrate	84	25
Hydrochlorothiazide	Hydrochlorothiazide	78	23
Allopurinol	Allopurinol	74	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	72	46
Januvia	Sitagliptin Phosphate	71	21
Furosemide	Furosemide	67	26
Atenolol	Atenolol	63	18
Ezetimibe	Ezetimibe	63	20
Donepezil Hcl	Donepezil Hcl	59	18
Lorazepam	Lorazepam	59	suppressed
Glipizide Er	Glipizide	57	17
Ozempic	Semaglutide	57	11
Azithromycin	Azithromycin	56	44
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	suppressed
Memantine Hcl	Memantine Hcl	53	12
Meloxicam	Meloxicam	51	15
Irbesartan	Irbesartan	49	16
Potassium Chloride	Potassium Chloride	45	14
Finasteride	Finasteride	43	11
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	15
Esomeprazole Magnesium	Esomeprazole Magnesium	41	16
Lovastatin	Lovastatin	41	suppressed
Carvedilol	Carvedilol	39	12
Clarithromycin	Clarithromycin	39	34
Gabapentin	Gabapentin	39	16
Sertraline Hcl	Sertraline Hcl	39	14
Tramadol Hcl	Tramadol Hcl	39	14
Alendronate Sodium	Alendronate Sodium	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Glipizide	Glipizide	36	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Famotidine	Famotidine	34	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Pregabalin	Pregabalin	32	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Baclofen	Baclofen	29	suppressed
Ramipril	Ramipril	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	28	suppressed
Methylprednisolone	Methylprednisolone	28	18
Prednisone	Prednisone	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Trazodone Hcl	Trazodone Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	21
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	14
Fluticasone Propionate	Fluticasone Propionate	24	12
Metformin Hcl Er	Metformin Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Naproxen	Naproxen	22	12
Warfarin Sodium	Warfarin Sodium	22	suppressed
Cephalexin	Cephalexin	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Diazepam	Diazepam	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	13
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Torsemide	Torsemide	20	suppressed
Fluocinonide	Fluocinonide	19	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Bumetanide	Bumetanide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Nystatin	Nystatin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Travoprost	Travoprost	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Propylthiouracil	Propylthiouracil	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Tobramycin	Tobramycin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Methimazole	Methimazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error